Prospective superficial EPR in-vivo dosimetry study during hypofractionated radiotherapy of breast cancer patients treated with helical tomotherapy

In-vivo dosimetry (IVD) is a patient specific measure of quality control and safety during radiotherapy. With regard to current reporting thresholds for significant occurrences in radiotherapy defined by German regulatory authorities, the present study examines the clinical feasibility of superficia...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Höfel, Sebastian (VerfasserIn) , Gandalini, Matteo (VerfasserIn) , Fix, Michael K. (VerfasserIn) , Drescher, Malte (VerfasserIn) , Zwicker, Felix (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 October 2021
In: Radiation oncology
Year: 2021, Jahrgang: 16, Pages: 1-13
ISSN:1748-717X
DOI:10.1186/s13014-021-01938-8
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13014-021-01938-8
Volltext
Verfasserangaben:Sebastian Höfel, Matteo Gandalini, Michael K. Fix, Malte Drescher and Felix Zwicker

MARC

LEADER 00000caa a2200000 c 4500
001 1788510682
003 DE-627
005 20220829100643.0
007 cr uuu---uuuuu
008 220204s2021 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13014-021-01938-8  |2 doi 
035 |a (DE-627)1788510682 
035 |a (DE-599)KXP1788510682 
035 |a (OCoLC)1341441254 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Höfel, Sebastian  |e VerfasserIn  |0 (DE-588)1251009743  |0 (DE-627)1788510461  |4 aut 
245 1 0 |a Prospective superficial EPR in-vivo dosimetry study during hypofractionated radiotherapy of breast cancer patients treated with helical tomotherapy  |c Sebastian Höfel, Matteo Gandalini, Michael K. Fix, Malte Drescher and Felix Zwicker 
264 1 |c 30 October 2021 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.02.2022 
520 |a In-vivo dosimetry (IVD) is a patient specific measure of quality control and safety during radiotherapy. With regard to current reporting thresholds for significant occurrences in radiotherapy defined by German regulatory authorities, the present study examines the clinical feasibility of superficial electron paramagnetic resonance (EPR) IVD of cumulative total doses applied to breast cancer patients treated with helical intensity-modulated radiotherapy (tomotherapy). 
650 4 |a Alanine 
650 4 |a Breast cancer 
650 4 |a EPR dosimetry 
650 4 |a Hypofractionated 
650 4 |a IMRT 
650 4 |a In vivo 
650 4 |a Lithium formate 
650 4 |a Radiotherapy 
650 4 |a Tomotherapy 
700 1 |a Gandalini, Matteo  |e VerfasserIn  |4 aut 
700 1 |a Fix, Michael K.  |e VerfasserIn  |4 aut 
700 1 |a Drescher, Malte  |d 1975-  |e VerfasserIn  |0 (DE-588)130475254  |0 (DE-627)50222035X  |0 (DE-576)189583800  |4 aut 
700 1 |a Zwicker, Felix  |d 1978-  |e VerfasserIn  |0 (DE-588)129202223  |0 (DE-627)390706892  |0 (DE-576)29753730X  |4 aut 
773 0 8 |i Enthalten in  |t Radiation oncology  |d London : BioMed Central, 2006  |g 16(2021), Artikel-ID 209, Seite 1-13  |h Online-Ressource  |w (DE-627)508725739  |w (DE-600)2224965-5  |w (DE-576)260614815  |x 1748-717X  |7 nnas  |a Prospective superficial EPR in-vivo dosimetry study during hypofractionated radiotherapy of breast cancer patients treated with helical tomotherapy 
773 1 8 |g volume:16  |g year:2021  |g elocationid:209  |g pages:1-13  |g extent:13  |a Prospective superficial EPR in-vivo dosimetry study during hypofractionated radiotherapy of breast cancer patients treated with helical tomotherapy 
856 4 0 |u https://doi.org/10.1186/s13014-021-01938-8  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220204 
993 |a Article 
994 |a 2021 
998 |g 129202223  |a Zwicker, Felix  |m 129202223:Zwicker, Felix  |d 50000  |e 50000PZ129202223  |k 0/50000/  |p 5  |y j 
999 |a KXP-PPN1788510682  |e 4051283070 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Sebastian","family":"Höfel","role":"aut","display":"Höfel, Sebastian","roleDisplay":"VerfasserIn"},{"display":"Gandalini, Matteo","roleDisplay":"VerfasserIn","role":"aut","family":"Gandalini","given":"Matteo"},{"given":"Michael K.","family":"Fix","role":"aut","roleDisplay":"VerfasserIn","display":"Fix, Michael K."},{"given":"Malte","family":"Drescher","role":"aut","display":"Drescher, Malte","roleDisplay":"VerfasserIn"},{"family":"Zwicker","given":"Felix","roleDisplay":"VerfasserIn","display":"Zwicker, Felix","role":"aut"}],"title":[{"title":"Prospective superficial EPR in-vivo dosimetry study during hypofractionated radiotherapy of breast cancer patients treated with helical tomotherapy","title_sort":"Prospective superficial EPR in-vivo dosimetry study during hypofractionated radiotherapy of breast cancer patients treated with helical tomotherapy"}],"language":["eng"],"recId":"1788510682","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 04.02.2022"],"name":{"displayForm":["Sebastian Höfel, Matteo Gandalini, Michael K. Fix, Malte Drescher and Felix Zwicker"]},"id":{"doi":["10.1186/s13014-021-01938-8"],"eki":["1788510682"]},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"30 October 2021"}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"London","dateIssuedDisp":"2006-","publisher":"BioMed Central","dateIssuedKey":"2006"}],"id":{"issn":["1748-717X"],"eki":["508725739"],"zdb":["2224965-5"]},"pubHistory":["1.2006 -"],"part":{"year":"2021","pages":"1-13","text":"16(2021), Artikel-ID 209, Seite 1-13","volume":"16","extent":"13"},"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 06.09.10"],"disp":"Prospective superficial EPR in-vivo dosimetry study during hypofractionated radiotherapy of breast cancer patients treated with helical tomotherapyRadiation oncology","language":["eng"],"recId":"508725739","title":[{"title":"Radiation oncology","title_sort":"Radiation oncology"}]}],"physDesc":[{"extent":"13 S."}]} 
SRT |a HOEFELSEBAPROSPECTIV3020